THE 2026 CALIBRATE RESULTS REPORT
Maximizing the Clinical and Economic Value of GLP-1 Therapy
GLP-1s work. Calibrate makes them last.
The 2026 Results Report draws on 50,000+ members and four years of real-world data — showing what sustained weight loss and metabolic improvement look like when clinical treatment meets behavioral support.
Download 2026 Results Report
Sustained weight loss over 4 years
Members keep losing weight past 12 months — rare with real-world GLP-1 use.
Best results in highest-risk members
Class II & III Obesity members lose 17–27% over four years — outcomes improve over time.
Metabolic health, not just weight
80% normalized HbA1c, 72% normalized insulin, and more within one year.
Engagement amplifies outcomes.
Active trackers see 17–24% better weight loss — participation is a clinical lever.